Loading clinical trials...
Loading clinical trials...
Pilot/Feasibility Study of CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Following Matched Related Allogeneic Hematopoietic Cell Transplantation for Patients With High-Risk Acute Lymphoblastic Leukemia
Conditions
Interventions
Allogeneic Hematopoietic Stem Cell Transplantation
Anti-CD19-CAR CMV-specific T-lymphocytes
+13 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
December 30, 2025
Primary Completion Date
March 7, 2029
Completion Date
March 7, 2029
Last Updated
April 27, 2026
NCT06074666
NCT04972942
NCT07295951
NCT06395103
NCT07523555
NCT04726241
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions